Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue.
Saved in:
| Title: | Cross-Resistance Among Sequential Cancer Therapeutics: An Emerging Issue. |
|---|---|
| Authors: | Loria R; Cellular Network and Molecular Therapeutic Target Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Vici P; Unit of Phase IV Trials, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Di Lisa FS; Unit of Phase IV Trials, IRCCS Regina Elena National Cancer Institute, Rome, Italy.; Medical Oncology A, Department of Radiological, Oncological, and Anatomo-Pathological Sciences, Umberto I University Hospital, University Sapienza, Rome, Italy., Soddu S; Cellular Network and Molecular Therapeutic Target Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Maugeri-Saccà M; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Bon G; Cellular Network and Molecular Therapeutic Target Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. |
| Source: | Frontiers in oncology [Front Oncol] 2022 Jun 23; Vol. 12, pp. 877380. Date of Electronic Publication: 2022 Jun 23 (Print Publication: 2022). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2022.877380 |
